Submitted by Anonymous (not verified) on 25 April 2024 - 10:59
Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation: 29/04/2022, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation: 29/04/2022, Revision: 6, Status: Authorised